Non-stochastic quadratic fingerprints and LDA-based QSAR models in hit and lead generation through virtual screening: theoretical and experimental assessment of a promising method for the discovery of new antimalarial compounds.
In order to explore the ability of non-stochastic quadratic indices to encode chemical information in antimalarials, four quantitative models for the discrimination of compounds having this property were generated and statistically compared. Accuracies of 90.2% and 83.3% for the training and test sets, respectively, were observed for the best of all the models, which included non-stochastic quadratic fingerprints weighted with Pauling electronegativities. With a comparative purpose and as a second validation experiment, an exercise of virtual screening of 65 already-reported antimalarials was carried out. Finally, 17 new compounds were classified as either active/inactive ones and experimentally evaluated for their potential antimalarial properties on the ferriprotoporphyrin (FP) IX biocrystallization inhibition test (FBIT). The theoretical predictions were in agreement with the experimental results. In the assayed test compound C5 resulted more active than chloroquine. The current result illustrates the usefulness of the TOMOCOMD-CARDD strategy in rational antimalarial-drug design, at the time that it introduces a new family of organic compounds as starting point for the development of promising antimalarials.
Department of Drug Design, CBQ, Central University of Las Villas, Santa Clara, Villa Clara, Cuba. alinamontero@gmail.com
Alina
A
Montero-Torres
Rory N
RN
García-Sánchez
Yovani
Y
Marrero-Ponce
Yanetsy
Y
Machado-Tugores
Juan J
JJ
Nogal-Ruiz
Antonio R
AR
Martínez-Fernández
Vicente J
VJ
Arán
Carmen
C
Ochoa
Alfredo
A
Meneses-Marcel
Francisco
F
Torrens
D000465:Algorithms; D000962:Antimalarials / Q000737:chemistry* / Q000145:classification / Q000494:pharmacology*; D002738:Chloroquine / Q000494:pharmacology; D003198:Computer Simulation; D003460:Crystallization; D015195:Drug Design; D004353:Drug Evaluation, Preclinical / Q000706:statistics & numerical data*; D006427:Hemin / Q000737:chemistry; D006571:Heterocyclic Compounds / Q000737:chemistry / Q000494:pharmacology; D008958:Models, Molecular; D008968:Molecular Conformation; D021281:Quantitative Structure-Activity Relationship; D015203:Reproducibility of Results
D000962:Antimalarials; D006571:Heterocyclic Compounds; D006427:Hemin; D002738:Chloroquine